X

Trial Profile

A clinical study of VTR-297 in treatment of onychomycosis

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 13 Nov 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Trichostatin A (Primary)
Indications Onychomycosis
Focus Adverse reactions

Most Recent Events

06 Nov 2024 According to a Vanda Pharmaceuticals media release, this e study is fully enrolled, and results are expected by the end of 2024.
06 Nov 2024 Status changed from recruiting to active, no longer recruiting as per a Vanda Pharmaceuticals media release.
31 Jul 2024 According to a Vanda Pharmaceuticals media release, this study was initiated in April 2024. The study is over 75% enrolled and is expected to be completed in the third quarter of 2024.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com